Sleep Pharmaceuticals Jazz Pharmaceuticals Presents Latest Advancements at World Sleep 2023 October 18, 2023 RTSleepWorld Read Article
Sleep Pharmaceuticals Promising Results for Narcolepsy Type 1 Treatment, but Safety Concerns Arise July 28, 2023 RTSleepWorld Read Article
Sleep Lab Magazine Sleep Lab Magazine SLEEP 2023 Conference Edition June 1, 2023 RTSleepWorld Read Article
Pharma Apnimed Sleep Apnea Pill Granted FDA Fast Track Designation July 1, 2022 RTSleepWorld Read Article
Sleep Pharmaceuticals Jazz to Present New Data at SLEEP 2022 Reinforcing Leadership in Sleep Medicine June 3, 2022 RTSleepWorld Read Article
Sleep Pharmaceuticals Investigational Sleep Apnea Pill Continues to Show Meaningful Benefit October 13, 2021 RTSleepWorld Read Article
Pharmaceuticals Apnimed Sleep Apnea Pill Secures $25 Million in Financing March 26, 2021 RTSleepWorld Read Article
Pharmaceuticals Jazz Gets FDA Approval of Xywav for Narcolepsy Related Cataplexy or EDS July 23, 2020 RTSleepWorld Read Article
Pharmaceuticals BELSOMRA Label Update Includes Insomnia Study Findings in Patients with Alzheimer’s Disease February 3, 2020 RTSleepWorld Read Article
Pharmaceuticals FDA Approves DAYVIGO for Treatment of Insomnia in Adults December 27, 2019 RTSleepWorld Read Article